Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study

Diabetes has been well recognized as a strong predictor for adverse outcomes after percutaneous coronary intervention (PCI), however, studies in the era of drug-eluting stent and potent P2Y12 inhibitors have shown conflicting results. We aimed to assess ischemic and bleeding outcomes after contemporary PCI according to diabetic status.

Source: Atherosclerosis - January 14, 2020 Category: Cardiology Authors: Ply Chichareon, Rodrigo Modolo, Norihiro Kogame, Kuniaki Takahashi, Chun-Chin Chang, Mariusz Tomaniak, Roberto Botelho, Eric Eeckhout, Sjoerd Hofma, Diana Trendafilova-Lazarova, Zsolt K őszegi, Andres Iñiguez, Joanna Wykrzykowska, Jan J. Piek, Scot Garg Source Type: research